Rapid cycling bipolar disorder: Historical overview and focus on emerging treatments

Bipolar Disorders

Volumn 6, Issue 6, 2004, Pages 523-529

  Mackin, Paul ^a   Young, Allan H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Anticonvulsants; Antidepressants; Atypical antipsychotics; Bipolar disorder; Diagnosis; Lithium; Rapid cycling; Treatment; Tricyclic antidepressants

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; ETIRACETAM; GABAPENTIN; ICOSAPENTAENOIC ACID; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM; MEXILETINE; OLANZAPINE; OMEGA 3 FATTY ACID; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

CLINICAL TRIAL; DEMOGRAPHY; DISEASE COURSE; DRUG MEGADOSE; HISTORY; HUMAN; MANIA; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RAPID CYCLING BIPOLAR DISORDER; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COGNITIVE THERAPY; HUMANS; LITHIUM CARBONATE; TRIAZINES;

EID: 9444263735     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2004.00156.x     Document Type: Review

References (71)

1. Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229-233.
2. Kilzieh N, Akiskal HS. Rapid-cycling bipolar disorder: an overview of research and clinical experience. Psychiatr Clin N Am 1999; 22: 585-607.
3. Maj M. Diagnosis and treatment of rapidly cycling bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2001; 251 (Suppl. 2):II62-II65.
4. Dubovsky SL. Rapid cycling bipolar disease: new concepts and treatments. Curr Psychiatry Rep 2001; 3: 451-462.
5. Barrios C, Chaudhry TA, Goodnick PJ. Rapid cycling bipolar disorder. Expert Opin Pharmacother 2001; 2: 1963-1973.
6. Goodwin FK, Jamison KR, Manic Depressive Illness. New York, NY: Oxford University Press, 1990.
7. Wolpert EA, Goldberg JF, Harrow M. Rapid cycling in unipolar and bipolar affective disorders. Am J Psychiatry 1990; 147: 725-728.
8. Tay LK, Dunner DL. A report on three patients with 'rapid cycling' unipolar depression. Compr Psychiatry 1992; 33: 253-255.
9. Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996; 168: 314-323.
10. Maj M, Magliano L, Pirozzi R et al. Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry 1994; 151: 1015-1019.
11. Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49: 126-131.
12. Koukopoulos A, Reginalsi D, Laddomada P. Course of the manic-depressive cycle and changes caused by treatments. Pharmacopsychiatry 1980; 13: 156-167.
13. Cowdry RW, Wehr TA, Zis AP et al. Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch Gen Psychiatry 1983; 40: 414-420.
14. Bauer MS, Calabrese J, Dunner DL et al. Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994; 151: 506-515.
15. Wehr TA, Sack DA, Rosenthal NE et al. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179-184.
16. Joffe RT, Kutcher S, MacDonald C. Thyroid function and bipolar affective disorder. Psychiatry Res 1988; 25: 117-121.
17. Calabrese JR, Shelton MD, Bowden CL et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001; 62 (Suppl. 14): 34-41.
18. Blackwell MJ. Rapid-cycling manic-depressive illness following subarachnoid haemorrhage. Br J Psychiatry 1991; 159: 279-280.
19. Zwil AS, McAllister TW, Cohen I et al. Ultra-rapid cycling bipolar affective disorder following a closed-head injury. Brain Inj 1993; 7: 147-152.
20. Murai T, Fujimoto S. Rapid cycling bipolar disorder after left temporal polar damage. Brain Inj 2003; 17: 355-358.
21. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990; 47: 435-440.
22. Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry 1990; 47: 427-432.
23. Post RM, Kramlinger KG, Joffe RT et al. Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psychiatry Res 1997; 72: 1-7.
24. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555-559.
25. Angst J. Switch from depression to mania - a record study over decades between 1920 and 1982. Psychopathology 1985; 18: 140-154.
26. Lewis JL, Winokur G. The induction of mania. A natural history study with controls. Arch Gen Psychiatry 1982; 39: 303-306.
27. Murphy DL. The behavioural toxicity of monoamine oxidase inhibiting antidepressants. Adv Pharmacol Chemother 1974; 14: 71-105.
28. Zis AP, Cowdry RW, Wehr TA et al. Tricyclic-induced mania and MHPG excretion. Psychiatry Res 1979; 1: 93-99.
29. Koukopoulos A, Caliari B, Tundo A. Rapid cyclers, temperament and antidepressants. Compr Psychiatry 1983; 24: 249-258.
30. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403-1411.
31. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164: 549-550.
32. Coryell W, Solomon D, Turvey C et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003; 60: 914-920.
33. Roy-Byrne PP, Post R, Uhde TW. The longitudinal course of recurrent affective illness: Life chart data from research patients at the NIMH. Acta Psychiatr Scand 1985; 71 (Suppl. 317): 1-34.
34. Kraepelin E, Manic Depressive Insanity and Paranoia. Edinburgh, UK: Livingstone, 1921.
35. Zis AP, Grof P, Webster M et al. Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 1980; 16: 47-49.
36. Angst J. Unsolved problems in the indications for lithium prophylaxis in affective and schizoaffective disorders. Bibl Psychiatr 1981; 161: 32-44.
37. Wehr TA, Goodwin FK. Do antidepressants cause mania? Psychopharmacol Bull 1987; 23: 61-65.
38. Cole AJ, Scott J, Ferrier IN et al. Patterns of treatment resistance in bipolar affective disorder. Acta Psychiatr Scand 1993; 88: 121-123.
39. Dunner DL, Fleiss JL, Fieve RR. Lithium carbonate prophylaxis failure. Br J Psychiatry 1976; 129: 40-44.
40. Goodwin GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994; 164: 149-152.
41. Okuma T, Inanaga K, Otsuki S et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology (Berl) 1981; 73: 95-96.
42. Denicoff KD, Smith-Jackson EE, Disney ER et al. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58: 470-478.
43. Calabrese JR, Woyshville MJ, Kimmel SE et al. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993; 13: 280-283.
44. Calabrese JR, Markovitz PJ, Kimmel SE et al. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992; 12 (Suppl. 1): 53S-56S.
45. Kupka R, Luckenbaugh D, Post R. Rapid and non-rapid cycling bipolar disorder: a comparative study using daily prospective mood ratings in 539 outpatients (abstract). Bipolar Disord 2003; 5 (Suppl. 1): 62.
46. Baldessarini RJ, Tondo L, Floris G et al. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000; 61: 13-22.
47. Kupka RW, Luckenbaugh DA, Post RM et al. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003; 64: 1483-1494.
48. Bowden CL, Calabrese JR, McElroy SL et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry 1999; 45: 953-958.
49. Calabrese JR, Bowden CL, Sachs GS et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79-88.
50. Frye MA, Ketter TA, Kimbrell TA et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20: 607-614.
51. Calabrese JR, Suppes T, Bowden CL et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841-850.
52. Marangell LB, Martinez JM, Ketter TA et al. Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. Bipolar Disord 2004; 6: 139-143.
53. Macritchie KA, Geddes JR, Scott J et al. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2001; 3: CDO03196.
54. Wang PW, Santosa C, Schumacher M et al. Gabapentin augmentation therapy in bipolar depression. Bipolar Disord 2002; 4: 296-301.
55. Schaffer LC, Schaffer CB. Tiagabine and the treatment of refractory bipolar disorder. Am J Psychiatry 1999; 156: 2014-2015.
56. Schaffer LC, Schaffer CB, Howe J. An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients. J Affect Disord 2002; 71: 259-263.
57. Grunze H, Langosch J, Born C et al. Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. J Clin Psychiatry 2003; 64: 781-784.
58. Braunig P, Kruger S. Levetiracetam in the treatment of rapid cycling bipolar disorder. J Psychopharmacol 2003; 17: 239-241.
59. Yatham LN. Efficacy of atypical antipsychotics in mood disorders. J Clin Psychopharmacol 2003; 23 (Suppl. 1): S9-S14.
60. Masan PS. Atypical antipsychotics in the treatment of affective symptoms: a review. Ann Clin Psychiatry 2004; 16: 3-13.
61. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995; 56: 423-429.
62. Coconcea C, Delgado P, Shelton MD et al. Risperidone augmentation in rapid-cycling bipolar disorder. Bipolar Disorders 2003; 5 (Suppl. 1): 40.
63. D'Souza R, Keks N, Scurrah M. Olanzapine in the treatment of rapid-cycling bipolar disorders: an open prospective study. Bipolar Disord 2003; 5 (Suppl. 1): 42-43.
64. Ghaemi SN, Goldberg JF, Henry C et al. Quetiapine for rapid-cycling bipolar disorder: a long-term follow-up study. Bipolar Disord 2003; 5 (Suppl. 1): 50.
65. Vieta E, Parramon G, Padrell E et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 2002; 4: 335-340.
66. Suppes T, Erkan Ozcan M, Carmody T. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. Bipolar Disord 2004; 6: 329-332.
67. Leibow D. L-Thyroxine for rapid-cycling bipolar illness. Am J Psychiatry 1983; 140: 1255.
68. Extein IL. High doses of levothyroxine for refractory rapid cycling. Am J Psychiatry 2000; 157: 1704-1705.
69. Stoll AL, Severus WE, Freeman MP et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56: 407-412.
70. Keck PE, Jr, McElroy SL, Freeman MP. Randomized, placebo-controlled trial of eicosapentanoic acid in rapid cycling bipolar disorder (abstract). Bipolar Disord 2003; 5 (Suppl. 1): 58.
71. Schaffer A, Levitt AJ, Joffe RT. Mexiletine in treatment-resistant bipolar disorder. J Affect Disord 2000; 57: 249-253.